Cytek Biosciences Inc
NASDAQ:CTKB
Cytek Biosciences Inc
Gross Profit
Cytek Biosciences Inc
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Cytek Biosciences Inc
NASDAQ:CTKB
|
Gross Profit
$109.4m
|
CAGR 3-Years
28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Gross Profit
$17.2B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
|
Danaher Corp
NYSE:DHR
|
Gross Profit
$25.6B
|
CAGR 3-Years
21%
|
CAGR 5-Years
23%
|
CAGR 10-Years
10%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Gross Profit
$2.2B
|
CAGR 3-Years
6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
Agilent Technologies Inc
NYSE:A
|
Gross Profit
$3.4B
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Gross Profit
$5.3B
|
CAGR 3-Years
9%
|
CAGR 5-Years
7%
|
CAGR 10-Years
14%
|
See Also
What is Cytek Biosciences Inc's Gross Profit?
Gross Profit
109.4m
USD
Based on the financial report for Dec 31, 2023, Cytek Biosciences Inc's Gross Profit amounts to 109.4m USD.
What is Cytek Biosciences Inc's Gross Profit growth rate?
Gross Profit CAGR 3Y
28%
Over the last year, the Gross Profit growth was 8%. The average annual Gross Profit growth rates for Cytek Biosciences Inc have been 28% over the past three years .